What is Quest Diagnostics, Inc. Annual Revenue?

Quest Diagnostics, Inc. Annual Revenue rose 6.7%, in the last year to $9,872 M. Its sector's average revenue growth for the last fiscal year was 8.5%.

What is Quest Diagnostics, Inc. Annual Net Profit?

Quest Diagnostics, Inc. Annual Net Profit rose 1.99% in the last year to $871 M. Its sector's average net profit growth for the last fiscal year was 13.48%.

What is Quest Diagnostics, Inc. Price to Earning Ratio?

Quest Diagnostics, Inc. Price to Earning Ratio is 20.62, lower than its sector PE ratio of 21.12.

What is Quest Diagnostics, Inc. Stock Price?

Quest Diagnostics, Inc. Stock Price rose 26.02% and outperformed its sector by 26.14% in the past year.

What is Quest Diagnostics, Inc. Quarterly Revenue?

Quest Diagnostics, Inc. Quarterly Revenue rose 14.55% YoY to $2,621 M. Its sector's average revenue growth YoY for the quarter was 10.69%.

What is Quest Diagnostics, Inc. Quarterly Net profit?

Quest Diagnostics, Inc. Quarterly Net profit rose 15.62% YoY to $222 M. Its sector's average net profit growth YoY for the quarter was 56.91%.

What is Quest Diagnostics, Inc. Debt to Equity Ratio?

Quest Diagnostics, Inc. Debt to Equity Ratio of 1.05 is higher than 1. This implies that company assets are financed through debt.

What is Quest Diagnostics, Inc. Return on Equity(ROE)?

Quest Diagnostics, Inc. Return on Equity(ROE) for the last financial year was 13.24%, in the normal range of 10% to 20%.

What is Quest Diagnostics, Inc. Mutual Fund Holding?

Quest Diagnostics, Inc. Mutual Fund Holding increased by 1.23% in the last quarter to 79.17.

What is Quest Diagnostics, Inc. Promoter Share Holding?

Quest Diagnostics, Inc. Promoter Share Holding increased by 0.01% in the most recent quarter to 0.35%.

What is Quest Diagnostics, Inc. Interest Coverage Ratio?

Quest Diagnostics, Inc. Interest Coverage Ratio is 6.2, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Quest Diagnostics, Inc. Institutional Holding?

Quest Diagnostics, Inc. Institutional Holding increased by 0.34% in the last quarter to 90.31.

How is the Quest Diagnostics, Inc. today?

The Quest Diagnostics, Inc. today is trading in the down by -1.18% at 161.86.

How has Quest Diagnostics, Inc. performed historically?

The Quest Diagnostics, Inc. is currently trading down -1.18% on an intraday basis in the past week the index fell -1.30%. The index has been up 7.05% in the past quarter and rose 26.02% in the past year. You can view this in the overview section.

Quest Diagnostics, Inc. XNYS: DGX

Quest Diagnostics, Inc. Live Share Price Today, Share Analysis and Chart

Name: Quest Diagnostics, Inc.: Is Infosys Ltd. worth buying?
Item: Quest Diagnostics, Inc.
Rating: 1.648652875
Author: Trendlyne DVM scores

Momentum Trap

Download real time

161.86 -1.94 (-1.18%)

26.08% Gain from 52W Low

1.3M XNYS Volume

XNYS 21 Apr, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Quest Diagnostics, Inc. is on 23 Apr 2025 for the purpose of Quest Diagnostics Inc First Quarter Earnings Results for 2025 See details

Quest Diagnostics, Inc. Key Metrics

My Metrics

Select

Market Capitalization Market Runner Up Unavailable in chosen country	17,962.9
PE TTM Below industry Median Unavailable in chosen country	20.6
PEG TTM Below industry Median Unavailable in chosen country	10.4
Price to Book Below industry Median Unavailable in chosen country	2.7
Institutional holding current Qtr % Market Runner Up Unavailable in chosen country	90.3
Revenue Growth Qtr YoY % Market Runner Up Unavailable in chosen country	14.6
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	6.7
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	15.6
Net Profit TTM Growth % Market Runner Up Unavailable in chosen country	2
Operating Profit Margin Qtr % Below industry Median Unavailable in chosen country	13.8
Operating Profit Margin TTM % Below industry Median Unavailable in chosen country	13.6
Piotroski Score Unavailable in chosen country	3
Rel Perf vs Sector quarter% Unavailable in chosen country	18.5
ROE Annual % Below industry Median Unavailable in chosen country	13.2
RoA Annual % Market Runner Up Unavailable in chosen country	5.7

All financials are in USD Million and price data in USD

Low Financial Strength

27.8 / 100

Expensive Valuation

29.2 / 100

Technically Neutral

47.2 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

179

1Yr Price target upside is 11%

17 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Strong Sell Zone

96.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Quest Diagnostics, Inc. Stock Price Analysis

Day Price Range -1.2% 1 Day return Unavailable in chosen country	161.9 (LTP) 160164 LowHigh
Week Price Range -1.3% 1 Week return Unavailable in chosen country	161.9 (LTP) 160169.7 LowHigh
Month Price Range -2.8% 1 Month return Unavailable in chosen country	161.9 (LTP) 157.2174 LowHigh
52 Week Price Range 26.0% 1 Year return Unavailable in chosen country	161.9 (LTP) 128.4178.9 LowHigh

View full Share Price History

Quest Diagnostics, Inc. Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Quest Diagnostics, Inc.'s Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

7.7

Avg. Estimate

8.5

Low Estimate

8.1

High Estimate

9.3

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 10.5% in FY25

Consensus Recommendation

19 ANALYST Recommendations

BUY

The consensus recommendation from 19 analysts for Quest Diagnostics, Inc. is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Quest Diagnostics, Inc. Stock Analysis

Quest Diagnostics, Inc. stock analysis with key metrics, changes, and trends.

Quest Diagnostics, Inc. Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$9,872 M	6.7%	positive	Annual Revenue rose 6.7%, in the last year to $9,872 M. Its sector's average revenue growth for the last fiscal year was 8.5%.
Annual Net Profit	$871 M	1.99%	positive	Annual Net Profit rose 1.99% in the last year to $871 M. Its sector's average net profit growth for the last fiscal year was 13.48%.
Price to Earning Ratio	20.62	-	positive	Price to Earning Ratio is 20.62, lower than its sector PE ratio of 21.12.
Stock Price	$161.86	26.02%	positive	Stock Price rose 26.02% and outperformed its sector by 26.14% in the past year.
Quarterly Revenue	$2,621 M	14.55%	positive	Quarterly Revenue rose 14.55% YoY to $2,621 M. Its sector's average revenue growth YoY for the quarter was 10.69%.
Quarterly Net profit	$222 M	15.62%	positive	Quarterly Net profit rose 15.62% YoY to $222 M. Its sector's average net profit growth YoY for the quarter was 56.91%.
Debt to Equity Ratio	1.05	-	negative	Debt to Equity Ratio of 1.05 is higher than 1. This implies that company assets are financed through debt.
Return on Equity(ROE)	13.24 %	13.24%	neutral	Return on Equity(ROE) for the last financial year was 13.24%, in the normal range of 10% to 20%.
Mutual Fund Holding	79.17 %	1.23%	positive	Mutual Fund Holding increased by 1.23% in the last quarter to 79.17.
Promoter Share Holding	0.35 %	0.01%	positive	Promoter Share Holding increased by 0.01% in the most recent quarter to 0.35%.
Interest Coverage Ratio	6.2	-	positive	Interest Coverage Ratio is 6.2, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
Institutional Holding	90.31 %	0.34%	positive	Institutional Holding increased by 0.34% in the last quarter to 90.31.

VIEW LESS

Loading data..

Quest Diagnostics, Inc. - Company Profile

What does Quest Diagnostics, Inc. do?

Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

2024

Gross Remuneration

Year

Quest Diagnostics, Inc. Live Share Price Today, Share Analysis and Chart

26.08% Gain from 52W Low

Quest Diagnostics, Inc. Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Quest Diagnostics, Inc. Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Quest Diagnostics, Inc. Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Quest Diagnostics, Inc.'s Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

EPS is expected to grow by 10.5% in FY25

Consensus Recommendation

The consensus recommendation from 19 analysts for Quest Diagnostics, Inc. is BUY

Quest Diagnostics, Inc. Stock Analysis

Quest Diagnostics, Inc. stock analysis with key metrics, changes, and trends.

Annual Revenue rose 6.7%, in the last year to $9,872 M. Its sector's average revenue growth for the last fiscal year was 8.5%.

Annual Net Profit rose 1.99% in the last year to $871 M. Its sector's average net profit growth for the last fiscal year was 13.48%.

Price to Earning Ratio is 20.62, lower than its sector PE ratio of 21.12.

Stock Price rose 26.02% and outperformed its sector by 26.14% in the past year.

Quarterly Revenue rose 14.55% YoY to $2,621 M. Its sector's average revenue growth YoY for the quarter was 10.69%.

Quarterly Net profit rose 15.62% YoY to $222 M. Its sector's average net profit growth YoY for the quarter was 56.91%.

Debt to Equity Ratio of 1.05 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE) for the last financial year was 13.24%, in the normal range of 10% to 20%.

Mutual Fund Holding increased by 1.23% in the last quarter to 79.17.

Promoter Share Holding increased by 0.01% in the most recent quarter to 0.35%.

Interest Coverage Ratio is 6.2, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding increased by 0.34% in the last quarter to 90.31.

Quest Diagnostics, Inc. - Company Profile

What does Quest Diagnostics, Inc. do?

Quest Diagnostics, Inc. Management structure

Mr. James E. Davis

Chairman of the Board, President and Chief Executive Officer

Mr. Sam A. Samad

Executive Vice President and Chief Financial Officer

Ms. Catherine T. Doherty

Executive Vice President, Regional Businesses

Mr. Michael E. Prevoznik

Senior Vice President and General Counsel

Mr. Karthik Kuppusamy

Senior Vice President, Clinical Solutions

Mr. Patrick Plewman

Senior Vice President, Diagnostic Services

Quest Diagnostics, Inc. Board of directors

Mr. Timothy M. Ring